# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3561973 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel. (Class of assay: confirmatory) | 558 | ALA1201862 | assay format | PubChem BioAssays | ||
2. | ALA3562085 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel. (Class of assay: confirmatory) | 558 | ALA1201862 | assay format | PubChem BioAssays | ||
3. | ALA3562088 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel. (Class of assay: confirmatory) | 570 | ALA1201862 | assay format | PubChem BioAssays | ||
4. | ALA3562112 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel. (Class of assay: confirmatory) | 556 | ALA1201862 | assay format | PubChem BioAssays | ||
5. | ALA3562133 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel. (Class of assay: confirmatory) | 570 | ALA1201862 | assay format | PubChem BioAssays | ||
6. | ALA3562135 | Functional | PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel. (Class of assay: confirmatory) | 556 | ALA1201862 | assay format | PubChem BioAssays | ||
7. | ALA3588316 | Functional | Antiviral activity against Cytomegalovirus AD-169 infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Cytomegalovirus | 15 | ALA3585293 | organism-based format | Scientific Literature | |
8. | ALA3588317 | Functional | Antiviral activity against Cytomegalovirus Davis infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Cytomegalovirus | 14 | ALA3585293 | organism-based format | Scientific Literature | |
9. | ALA3588318 | ADME | Cytotoxicity against HEL cells assessed as alternation of cell morphology by microscopic analysis | Homo sapiens | 16 | ALA3585293 | cell-based format | Scientific Literature | |
10. | ALA3588321 | Functional | Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 1 | 8 | ALA3585293 | organism-based format | Scientific Literature | |
11. | ALA3588391 | Functional | Antiviral activity against thymidine kinase-deficient acyclovir-resistant Herpes simplex virus 1 KOS infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 1 | 8 | ALA3585293 | organism-based format | Scientific Literature | |
12. | ALA3588392 | Functional | Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Human alphaherpesvirus 2 | 8 | ALA3585293 | organism-based format | Scientific Literature | |
13. | ALA3588393 | Functional | Antiviral activity against Vaccinia virus infected in HEL cells assessed as reduction of virus-induced cytopathogenicity | Vaccinia virus | 8 | ALA3585293 | organism-based format | Scientific Literature | |
14. | ALA3626038 | Functional | Antiviral activity against human cytomegalovirus AD169 infected in HEL cells assessed as reduction in viral plaque formation | Human betaherpesvirus 5 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
15. | ALA3626039 | Functional | Antiviral activity against human cytomegalovirus Davis infected in HEL cells assessed as reduction in viral plaque formation | Human betaherpesvirus 5 | 21 | ALA3621200 | organism-based format | Scientific Literature | |
16. | ALA3626040 | ADME | Cytotoxicity against human cytomegalovirus infected HEL cells assessed as alteration of cell morphology incubated for 3 days by microscopy | Homo sapiens | 21 | ALA3621200 | cell-based format | Scientific Literature | |
17. | ALA3626041 | ADME | Cytotoxicity against human cytomegalovirus infected HEL cells assessed as cell growth inhibition incubated for 3 days by coulter counter method | Homo sapiens | 14 | ALA3621200 | cell-based format | Scientific Literature | |
18. | ALA3632124 | ADME | Cytotoxicity against human HEL cells assessed as alteration in cell morphology incubated for 3 days by microscopy | Homo sapiens | 5 | ALA3627667 | cell-based format | Scientific Literature | |
19. | ALA3632125 | ADME | Cytotoxicity against human HEL cells assessed as cell growth reduction incubated for 3 days | Homo sapiens | 5 | ALA3627667 | cell-based format | Scientific Literature | |
20. | ALA3632126 | Functional | Antiviral activity against Human cytomegalovirus AD169 expressed in HEL cells assessed as reduction in plaque formation incubated for 7 days by Giemsa stain based microscopy | Human betaherpesvirus 5 | 5 | ALA3627667 | organism-based format | Scientific Literature |